Anke Kretz-Rommel
Technik-/Wissenschafts-/F&E-Leiter bei Bird Rock Bio, Inc.
Profil
Anke Kretz-Rommel is currently the Chief Technology Officer at Bird Rock Bio, Inc. Previously, she worked as a Principal at Alexion Antibody Technologies.
She holds a doctorate degree from the Swiss Federal Institute of Technology.
Aktive Positionen von Anke Kretz-Rommel
| Unternehmen | Position | Beginn |
|---|---|---|
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Technik-/Wissenschafts-/F&E-Leiter | 27.08.2009 |
Ehemalige bekannte Positionen von Anke Kretz-Rommel
| Unternehmen | Position | Ende |
|---|---|---|
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Corporate Officer/Principal | - |
Ausbildung von Anke Kretz-Rommel
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
